SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-186973
Filing Date
2014-05-07
Accepted
2014-05-07 13:13:08
Documents
9
Period of Report
2014-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d722990d8k.htm 8-K 37720
2 EX-10.1 d722990dex101.htm EX-10.1 811108
3 EX-10.3 d722990dex103.htm EX-10.3 813154
4 EX-10.5 d722990dex105.htm EX-10.5 780016
5 EX-10.7 d722990dex107.htm EX-10.7 149530
6 EX-10.8 d722990dex108.htm EX-10.8 157944
7 EX-10.9 d722990dex109.htm EX-10.9 160299
8 EX-99.1 d722990dex991.htm EX-99.1 13070
9 GRAPHIC g722990g66s78.jpg GRAPHIC 14896
  Complete submission text file 0001193125-14-186973.txt   2944985
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 1 416-216-0000
Endo International plc (Filer) CIK: 0001593034 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36326 | Film No.: 14819952
SIC: 2834 Pharmaceutical Preparations